Erythema Nodosum Migrans: Definition and Clinical Entity
Erythema nodosum migrans (ENM), also known as subacute nodular migratory panniculitis or Bäfverstedt syndrome, is a rare clinical variant of erythema nodosum characterized by unilateral, centrifugally expanding, relatively painless subcutaneous nodules or plaques that exhibit peripheral migration with central clearing, typically affecting the lower extremities.
Clinical Characteristics
ENM presents with distinct features that differentiate it from classic erythema nodosum:
- Unilateral presentation (unlike bilateral distribution in classic erythema nodosum)
- Migratory pattern with centrifugal expansion and tendency toward central clearing, creating a peripheral ring appearance 1, 2
- Less painful than typical erythema nodosum nodules 3
- Morpheaform quality with slightly indurated, erythematous plaques 3, 2
- Predominantly affects lower legs, particularly the shin area 4, 5
Demographics and Epidemiology
ENM most commonly affects women in the third to sixth decade of life 4, though cases have been reported in younger patients and males 6, 4. The condition is considerably rarer than classic erythema nodosum.
Histopathologic Features
The histopathology of ENM shows distinctive septal granulomatous panniculitis with specific features that justify its classification as a unique clinicopathologic entity 1:
- Markedly thickened and fibrotic septa
- Marked capillary proliferation resembling granulation tissue
- Massive granulomatous reaction with giant cells along widened septal borders
- Absence of hemorrhage and phlebitis (unlike chronic erythema nodosum) 1
- Non-specific focal panniculitis pattern 7
Etiology and Associated Conditions
Most cases are idiopathic 4, 2. When identifiable triggers exist, they include:
- Streptococcal infections 4, 5
- Thyroid disease 4
- Hepatitis B infection 4
- Medications (particularly valsartan) 3
- Borrelia burgdorferi infection (rare) 8, 5
Important Clinical Pitfalls
Differentiation from Erythema Migrans (Lyme Disease)
Do not confuse erythema nodosum migrans with erythema migrans—these are completely different entities 9:
- Erythema migrans is the pathognomonic rash of Lyme disease, appearing at the tick bite site 7-14 days post-bite, requiring ≥5 cm diameter for diagnosis, and representing active Borrelia burgdorferi infection 9, 10
- Erythema nodosum migrans is a panniculitis with subcutaneous nodules that migrate peripherally, unrelated to tick bites in most cases
Differentiation from Classic Erythema Nodosum
While some consider ENM simply a variant of erythema nodosum 7, 11, sufficient clinical and histopathologic differences exist to justify ENM as a distinct entity 1:
- Classic EN: bilateral, anterior tibial areas, very tender, associated with systemic symptoms, shows phlebitis and hemorrhage histologically 12, 13
- ENM: unilateral, migratory with central clearing, less painful, distinct histopathology without phlebitis 1
Treatment Approach
Potassium iodide (SSKI) is the most consistently effective treatment for ENM 4, 6, 2:
- Saturated solution of potassium iodide as first-line therapy
- Combination with topical heparin may enhance response 2
- Short-course systemic corticosteroids (prednisone 20 mg daily for 7 days, then 10 mg for 7 days) for refractory cases 3
- Discontinue any suspected triggering medications (e.g., valsartan) 3
- Treat underlying infections if identified (e.g., ceftriaxone or doxycycline for Borrelia) 8, 5
NSAIDs and bed rest alone are typically insufficient for ENM, unlike classic erythema nodosum where they may be adequate 7.
Diagnostic Workup
Clinical diagnosis is primary, but in atypical cases:
- Skin biopsy confirms septal granulomatous panniculitis with characteristic features 1, 11
- Rule out infectious triggers (streptococcal serology, Borrelia serology if endemic area with tick exposure)
- Thyroid function tests
- Review medication history for potential drug triggers
- Consider hepatitis B serology if risk factors present